Company's step-down wholly owned subsidiary Strides Pharma Global Pte Ltd, Singapore, has received approval for Oxybutynin Chloride Tablets USP, 5 mg from the United States Food & Drug Administration (USFDA), Strides said in a filing to BSE.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3p3k0Sd
via IFTTT
0 comments:
Post a Comment